"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","characteristics_ch1.3","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","extract_protocol_ch1.1","taxid_ch1","description","data_processing","data_processing.1","data_processing.2","data_processing.3","data_processing.4","data_processing.5","data_processing.6","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","data_row_count","instrument_model","library_selection","library_source","library_strategy","relation","relation.1","supplementary_file_1","cell compartment:ch1","cell line:ch1","cell type:ch1","treatment:ch1"
"GSM4125727","Ctrl A1","GSM4125727","Public on Jun 14 2020","Oct 16 2019","Jun 14 2020","SRA","1","pancreatic cancer cell-derived exosomes","Homo sapiens","cell type: pancreatic cancer cell lines","cell line: mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","cell compartment: exosome","treatment: unirradiated","10Gy X-radiation treatment was used for generating dying tumor cells. Exosomes were purified from the conditioned media using differential ultracentrifugation. Centrifugation was performed at 300 g, 2,000 g and 10,000 g to remove the live cells, dead cells and cell debris, respectively. The supernant was further purified using 0.22um filters. The crude extract of exosomes was obtained by ultracentrifugation (100,000 g). And the pallet was washed using PBS to remove the contaminated protein.","Pancreatic cell lines PANC-1, MIA PaCa-2 and BxPC-3 were cultured with DMEM medium (Dulbecco’s Modified Eagle Medium, HyClone) with 2% FBS (Fetal Bovirne Serum with exosome depleting). SW1990 was cultured with 1640 medium (Roswell Park Memorial Institute-1640, HyClone) with 2% FBS(Fetal Bovirne Serum with exosome depleting).","total RNA","Total RNA was extracted using the Trizol reagent (Life technology) according to the manufacturer's instructions.","RNA libraries were prepared for sequencing using standard Illumina protocols, and ~150 bp PCR amplicons (corresponding to ~22nt miRNAs) were selected","9606","exosome-derived total RNA","Basecalls were performed using CASAVA version 1.8","The adaptor sequences were trimmed and the adaptor-trimmed-reads (>= 15nt) were left by cutadapt software (v1.9.3).","Trimmed reads from all samples were pooled, and miRDeep2 software (v2.0.0.5) was used to predict novel miRNAs","The trimmed reads were aligned to the merged human pre-miRNA databases (known pre-miRNA from miRBase plus the newly predicted pre-miRNAs) using Novoalign software (v3.02.12) with at most one mismatch","The read counts were normalized by TPM (tag counts per million aligned miRNAs) approach. Differentially expressed miRNAs between two samples were filtered through Fold change. Ddifferentially expressed miRNA between two groups were filtered by Fold Change and P-value.","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include tag reads, and normalized data (TPM), etc.","GPL11154","Ling,,Tian","TL09168@hotmail.com","Shanghai Key Laboratory of Pancreatic Diseases","Institute of Translational Medicine","Shanghai General Hospital","No. 650, New Songjiang Road","Shanghai","Shanghai","201620","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13041528","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7007261","NONE","exosome","mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","pancreatic cancer cell lines","unirradiated"
"GSM4125728","Ctrl A2","GSM4125728","Public on Jun 14 2020","Oct 16 2019","Jun 14 2020","SRA","1","pancreatic cancer cell-derived exosomes","Homo sapiens","cell type: pancreatic cancer cell lines","cell line: mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","cell compartment: exosome","treatment: unirradiated","10Gy X-radiation treatment was used for generating dying tumor cells. Exosomes were purified from the conditioned media using differential ultracentrifugation. Centrifugation was performed at 300 g, 2,000 g and 10,000 g to remove the live cells, dead cells and cell debris, respectively. The supernant was further purified using 0.22um filters. The crude extract of exosomes was obtained by ultracentrifugation (100,000 g). And the pallet was washed using PBS to remove the contaminated protein.","Pancreatic cell lines PANC-1, MIA PaCa-2 and BxPC-3 were cultured with DMEM medium (Dulbecco’s Modified Eagle Medium, HyClone) with 2% FBS (Fetal Bovirne Serum with exosome depleting). SW1990 was cultured with 1640 medium (Roswell Park Memorial Institute-1640, HyClone) with 2% FBS(Fetal Bovirne Serum with exosome depleting).","total RNA","Total RNA was extracted using the Trizol reagent (Life technology) according to the manufacturer's instructions.","RNA libraries were prepared for sequencing using standard Illumina protocols, and ~150 bp PCR amplicons (corresponding to ~22nt miRNAs) were selected","9606","exosome-derived total RNA","Basecalls were performed using CASAVA version 1.8","The adaptor sequences were trimmed and the adaptor-trimmed-reads (>= 15nt) were left by cutadapt software (v1.9.3).","Trimmed reads from all samples were pooled, and miRDeep2 software (v2.0.0.5) was used to predict novel miRNAs","The trimmed reads were aligned to the merged human pre-miRNA databases (known pre-miRNA from miRBase plus the newly predicted pre-miRNAs) using Novoalign software (v3.02.12) with at most one mismatch","The read counts were normalized by TPM (tag counts per million aligned miRNAs) approach. Differentially expressed miRNAs between two samples were filtered through Fold change. Ddifferentially expressed miRNA between two groups were filtered by Fold Change and P-value.","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include tag reads, and normalized data (TPM), etc.","GPL11154","Ling,,Tian","TL09168@hotmail.com","Shanghai Key Laboratory of Pancreatic Diseases","Institute of Translational Medicine","Shanghai General Hospital","No. 650, New Songjiang Road","Shanghai","Shanghai","201620","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13041526","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7007262","NONE","exosome","mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","pancreatic cancer cell lines","unirradiated"
"GSM4125729","Rad B1","GSM4125729","Public on Jun 14 2020","Oct 16 2019","Jun 14 2020","SRA","1","pancreatic cancer cell-derived exosomes","Homo sapiens","cell type: pancreatic cancer cell lines","cell line: mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","cell compartment: exosome","treatment: irradiated","10Gy X-radiation treatment was used for generating dying tumor cells. Exosomes were purified from the conditioned media using differential ultracentrifugation. Centrifugation was performed at 300 g, 2,000 g and 10,000 g to remove the live cells, dead cells and cell debris, respectively. The supernant was further purified using 0.22um filters. The crude extract of exosomes was obtained by ultracentrifugation (100,000 g). And the pallet was washed using PBS to remove the contaminated protein.","Pancreatic cell lines PANC-1, MIA PaCa-2 and BxPC-3 were cultured with DMEM medium (Dulbecco’s Modified Eagle Medium, HyClone) with 2% FBS (Fetal Bovirne Serum with exosome depleting). SW1990 was cultured with 1640 medium (Roswell Park Memorial Institute-1640, HyClone) with 2% FBS(Fetal Bovirne Serum with exosome depleting).","total RNA","Total RNA was extracted using the Trizol reagent (Life technology) according to the manufacturer's instructions.","RNA libraries were prepared for sequencing using standard Illumina protocols, and ~150 bp PCR amplicons (corresponding to ~22nt miRNAs) were selected","9606","exosome-derived total RNA","Basecalls were performed using CASAVA version 1.8","The adaptor sequences were trimmed and the adaptor-trimmed-reads (>= 15nt) were left by cutadapt software (v1.9.3).","Trimmed reads from all samples were pooled, and miRDeep2 software (v2.0.0.5) was used to predict novel miRNAs","The trimmed reads were aligned to the merged human pre-miRNA databases (known pre-miRNA from miRBase plus the newly predicted pre-miRNAs) using Novoalign software (v3.02.12) with at most one mismatch","The read counts were normalized by TPM (tag counts per million aligned miRNAs) approach. Differentially expressed miRNAs between two samples were filtered through Fold change. Ddifferentially expressed miRNA between two groups were filtered by Fold Change and P-value.","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include tag reads, and normalized data (TPM), etc.","GPL11154","Ling,,Tian","TL09168@hotmail.com","Shanghai Key Laboratory of Pancreatic Diseases","Institute of Translational Medicine","Shanghai General Hospital","No. 650, New Songjiang Road","Shanghai","Shanghai","201620","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13041525","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7007263","NONE","exosome","mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","pancreatic cancer cell lines","irradiated"
"GSM4125730","Rad B2","GSM4125730","Public on Jun 14 2020","Oct 16 2019","Jun 14 2020","SRA","1","pancreatic cancer cell-derived exosomes","Homo sapiens","cell type: pancreatic cancer cell lines","cell line: mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","cell compartment: exosome","treatment: irradiated","10Gy X-radiation treatment was used for generating dying tumor cells. Exosomes were purified from the conditioned media using differential ultracentrifugation. Centrifugation was performed at 300 g, 2,000 g and 10,000 g to remove the live cells, dead cells and cell debris, respectively. The supernant was further purified using 0.22um filters. The crude extract of exosomes was obtained by ultracentrifugation (100,000 g). And the pallet was washed using PBS to remove the contaminated protein.","Pancreatic cell lines PANC-1, MIA PaCa-2 and BxPC-3 were cultured with DMEM medium (Dulbecco’s Modified Eagle Medium, HyClone) with 2% FBS (Fetal Bovirne Serum with exosome depleting). SW1990 was cultured with 1640 medium (Roswell Park Memorial Institute-1640, HyClone) with 2% FBS(Fetal Bovirne Serum with exosome depleting).","total RNA","Total RNA was extracted using the Trizol reagent (Life technology) according to the manufacturer's instructions.","RNA libraries were prepared for sequencing using standard Illumina protocols, and ~150 bp PCR amplicons (corresponding to ~22nt miRNAs) were selected","9606","exosome-derived total RNA","Basecalls were performed using CASAVA version 1.8","The adaptor sequences were trimmed and the adaptor-trimmed-reads (>= 15nt) were left by cutadapt software (v1.9.3).","Trimmed reads from all samples were pooled, and miRDeep2 software (v2.0.0.5) was used to predict novel miRNAs","The trimmed reads were aligned to the merged human pre-miRNA databases (known pre-miRNA from miRBase plus the newly predicted pre-miRNAs) using Novoalign software (v3.02.12) with at most one mismatch","The read counts were normalized by TPM (tag counts per million aligned miRNAs) approach. Differentially expressed miRNAs between two samples were filtered through Fold change. Ddifferentially expressed miRNA between two groups were filtered by Fold Change and P-value.","Genome_build: hg19","Supplementary_files_format_and_content: .xlsx files include tag reads, and normalized data (TPM), etc.","GPL11154","Ling,,Tian","TL09168@hotmail.com","Shanghai Key Laboratory of Pancreatic Diseases","Institute of Translational Medicine","Shanghai General Hospital","No. 650, New Songjiang Road","Shanghai","Shanghai","201620","China","0","Illumina HiSeq 2000","size fractionation","transcriptomic","miRNA-Seq","BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN13041524","SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX7007264","NONE","exosome","mixture of PANC-1, SW1990, BxPC-3, MIA PaCa-2","pancreatic cancer cell lines","irradiated"
